 |
General Description |
Restlessness, drowsiness, fatigue and lassitude, Insomnia, headache, confusion, dizziness, Extrapyramidal Reactions (EPS), Parkinsonian-like symptoms may include bradykinesia, tremor, cogwheel rigidity, mask-like faces, Tardive dyskinesia, Motor restlessness (akathisia), Neuroleptic Malignant Syndrome, galactorrhea, amenorrhea, gynecomastia, impotence secondary to hyperprolactinemia, Cardiovascular adverse reaction, Nausea and bowel disturbances, primarily diarrhea, urinary frequency and incontinence, allergic reactions, visual disturbances, porphyria |
|
Direction of use |
whenever stimulation of gastrointestinal motility might be dangerous, e.g., in the presence of gastrointestinal hemorrhage, mechanical obstruction, or perforation In patients suffering from pheochromocytoma because the drug may cause a hypertensive crisis, probably due to release of catecholamines from the tumor in patients with known sensitivity or intolerance to metoclopramide in epileptics or patients receiving other drugs which are likely to cause extrapyramidal reactions, since the frequency and severity of seizures or extrapyramidal reactions may be increased |
